Short Interest in Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Decreases By 43.8%

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a large decline in short interest during the month of July. As of July 15th, there was short interest totaling 456 shares, a decline of 43.8% from the June 30th total of 812 shares. Approximately 0.1% of the company’s stock are short sold. Based on an average daily volume of 3,103 shares, the short-interest ratio is currently 0.1 days.

Innovator IBD Breakout Opportunities ETF Price Performance

Shares of NYSEARCA BOUT traded down $0.55 during trading on Wednesday, hitting $46.21. The stock had a trading volume of 377 shares, compared to its average volume of 4,056. Innovator IBD Breakout Opportunities ETF has a 12 month low of $35.05 and a 12 month high of $49.41. The firm has a fifty day moving average of $47.01 and a two-hundred day moving average of $43.12. The company has a market capitalization of $16.17 million, a PE ratio of 28.69 and a beta of 1.03.

Institutional Trading of Innovator IBD Breakout Opportunities ETF

A number of institutional investors have recently modified their holdings of BOUT. Osaic Holdings Inc. lifted its holdings in Innovator IBD Breakout Opportunities ETF by 39.7% during the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock worth $77,000 after purchasing an additional 597 shares in the last quarter. Comprehensive Wealth Management LLC grew its stake in Innovator IBD Breakout Opportunities ETF by 122.0% in the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after buying an additional 12,859 shares in the last quarter. Finally, Susquehanna International Group LLP increased its stake in Innovator IBD Breakout Opportunities ETF by 42.6% in the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after acquiring an additional 7,817 shares during the last quarter.

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.